Summary
The current standard-of-care for colorectal carcinoma (CRC) is a combination of chemotherapeutics, often supplemented with targeted biological drugs. Despite recent improvements, an urgent need exists for improved efficacy, especially at late-stage disease, and minimized side...
More information & hyperlinks
Web resources: | https://epgl.unige.ch/mol-pharmacology/88_OPTIM_en.html |